Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click
here.
Loading metrics
Open Access
Correction
Correction: Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma
Yao Liang,
Osamu Maeda,
Chiaki Kondo,
Kazuki Nishida,
Yuichi Ando
Correction: Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma